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Abstract
Background: Assisted reproductive technology (ART) has been associated with low birth weight of fresh embryo
transfer (FRESH) derived and increased birth weight of frozen embryo transfer (FET)-derived newborns. Owing to that,
we focused on imprinted insulin-like growth factor 2 (IGF2)/H19 locus known to be important for normal growth. This
locus is regulated by H19 imprinting control region (ICR) with seven binding sites for the methylation-sensitive zinc
finger regulatory protein (CTCF). A polymorphism rs10732516 G/A in the sixth binding site for CTCF, associates with
a genotype-specific trend to the DNA methylation. Due to this association, 62 couples with singleton pregnancies
derived from FRESH (44 IVF/18 ICSI), 24 couples from FET (15 IVF/9 ICSI), and 157 couples with spontaneously
conceived pregnancies as controls were recruited in Finland and Estonia for genotype-specific examination. DNA
methylation levels at the H19 ICR, H19 DMR, and long interspersed nuclear elements in placental tissue were explored
by MassARRAY EpiTYPER (n = 122). Allele-specific changes in the methylation level of H19 ICR in placental tissue (n = 26)
and white blood cells (WBC, n = 8) were examined by bisulfite sequencing. Newborns’ (n = 243) anthropometrics was
analyzed by using international growth standards.
Results: A consistent trend of genotype-specific decreased methylation level was observed in paternal allele of
rs10732516 paternal A/maternal G genotype, but not in paternal G/maternal A genotype, at H19 ICR in ART placentas.
This hypomethylation was not detected in WBCs. Also genotype-specific differences in FRESH-derived newborns’ birth
weight and head circumference were observed (P = 0.04, P = 0.004, respectively): FRESH-derived newborns with G/G
genotype were heavier (P = 0.04) and had larger head circumference (P = 0.002) compared to newborns with A/A
genotype. Also, the placental weight and birth weight of controls, FRESH- and FET-derived newborns differed
significantly in rs10732516 A/A genotype (P = 0.024, P = 0.006, respectively): the placentas and newborns of FET-derived
pregnancies were heavier compared to FRESH-derived pregnancies (P = 0.02, P = 0.004, respectively).
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Conclusions: The observed DNA methylation changes together with the phenotypic findings suggest that rs10732516
polymorphism associates with the effects of ART in a parent-of-origin manner. Therefore, this polymorphism should be
considered when the effects of environmental factors on embryonic development are studied.
Keywords: Assisted reproductive technology, IVF, Fresh embryo transfer, Frozen embryo transfer, Imprinting, IGF2/H19,
rs10732516, DNA methylation, Placenta, Birth weight,
Background
Although the results of assisted reproductive technology
(ART) in Western countries are impressive and the
children born are generally healthy, they have been asso-
ciated with increased risk of adverse perinatal outcome
[1]. Especially, an increased risk of low birth weight and
preterm birth have been observed in in vitro fertilized
(IVF) singleton pregnancies compared to natural con-
ception [2–4]. Furthermore, there has been a suspicion
of a higher frequency of imprinting disorders, such as
Angelman, Beckwith-Wiedemann, and Silver-Russell
syndromes [5, 6]. On the other hand, increased birth
weight has been associated with newborns derived from
frozen embryo transfer (FET) [7–9]. The reason for the
differences in perinatal outcome is unclear, but it could
be explained by parental characteristics, subfertility, or
gonadotrophin stimulation of the ovaries [10–12]. Fur-
thermore, some adverse effect of laboratory procedures
involving use of culture media, prolonged culturing of
the embryos and freezing/thawing methods has not been
excluded [10].
The procedures of IVF and intracytoplasmic sperm
injection (ICSI) are performed in the beginning of
embryonic development, which is a period of epigenetic
reprogramming. During this dynamic period of cell divi-
sions, the epigenetic marks are erased and then estab-
lished again [13]. The adequate methylation profiles are
needed for normal embryonic development, and indeed,
it has been recently shown that many developmentally
important transcription factors display preference for
sequences containing DNA methylation [14]. Altered
levels of DNA methylation have been observed not only
in different human tissues derived from IVF/ICSI preg-
nancies [15–17] but also in mouse [18, 19], suggesting
that IVF protocol, even without infertility can alter the
epigenome. Although the results are inconsistent, theor-
etically IVF could affect the epigenetic reprogramming
of early embryo and consequently influence the perinatal
outcome.
Owing to the low birth weight associated with IVF and
increased birth weight of newborns derived from FET,
we focused on the imprinted insulin-like growth factor 2
(IGF2)/H19 locus on chromosome 11p15.5. These two
genes are expressed in parent-of-origin manner; IGF2, a
major driver of growth, is expressed from paternal allele
[20] and non-coding, negative growth controller H19
from maternal allele [21]. Allele-specific gene expression
is needed for normal placental and embryonic growth.
The locus is regulated by allele-specific DNA methylation
at the H19 imprinting control region (H19 ICR) locating
between the genes, as well as H19 promoter region (H19
DMR) and three differentially methylated regions (DMR0,
DMR1, and DMR2) at the IGF2 (Fig. 1). H19 ICR contains
seven binding sites for a methylation-sensitive, zinc-finger
protein CCCTC-binding factor (CTCF). These binding
factors organize chromatin contacts and have a critical
role in the establishment and maintenance of imprinting
[22]. According to mouse studies, unmethylated H19 ICR
sequence on the maternal allele enables binding of the
CTCF protein, which is required to prevent enhancers
from acting on maternal IGF2, thus, repressing its expres-
sion [23].
Imprinting disorders have shown the importance of the
adequate H19 ICR methylation: hypomethylation results in
downregulation of IGF2 and biallelic expression of H19,
leading to a growth restriction disorder, Silver-Russell syn-
drome. By contrast, hypermethylation of H19 ICR leads to
overexpression of IGF2, downregulation of H19, and conse-
quently fetal over-growth known as Beckwith-Wiedemann
syndrome [24, 25]. Hypomethylation of the sixth CTCF
binding site (CTCF6) at the H19 ICR has been previously
associated with placental cells [15], buccal epithelium cells
[16], and cord blood mononuclear cells [17] in human
pregnancies conceived by IVF or ICSI. Also, increased
inter- and intra-individual variation in allele-specific DNA
methylation and decreased IGF2 and H19 expression have
been observed in placental tissue of in vitro conceived
children [26].
In our recent study, we observed a single nucleotide
polymorphism rs10732516 G/A in CTCF6, which associ-
ated with the distinct DNA methylation profiles of H19
ICR in human placenta [27]. Moreover, when the sam-
ples were divided in four groups according to the geno-
type (rs10732516 G/G, paternal G/maternal A, paternal
A/maternal G, and A/A), we observed decreased methy-
lation level in alcohol-exposed placentas of paternal A/
maternal G genotype, but not in paternal G/maternal A
genotype. Surprisingly, alcohol exposure associated with
decreased head circumference in all genotypes except A/
A, in which increased head circumference was observed
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[27]. Interestingly, previous studies have shown
parent-of-origin associations between birth weight and
polymorphisms rs4929984 and rs2071094, which both
are in linkage to rs10732516 [28, 29].
Although prenatal alcohol exposure and IVF are very
different environmental factors, they both have been asso-
ciated with growth-restricted phenotype of newborns. To
examine if there is similar genotype-specific decreased
DNA methylation level at the IGF2/H19 locus caused by
ART, we collected placental tissue from fresh embryo
transfer (FRESH) and frozen embryo transfer (FET)-der-
ived pregnancies of Finnish and Estonian couples (Table 1;
Additional file 1: Table S1). We compared them to placen-
tas of spontaneous, naturally conceived pregnancies. We
explored the methylation levels of H19 ICR and H19
DMR in placenta. Owing to the previously detected
ART-associated changes in global DNA methylation levels
[30], also long interspersed nuclear elements (LINE-1)
were examined. In addition to placenta, we collected
umbilical cord blood to explore if we could see similar
changes in DNA methylation in both extra embryonic
placental cells and embryonic blood cells of the newborns.
Potential genotype-specific effects of ART on the new-
borns’ phenotype were studied by using international
growth standards [31].
Results
Participants characteristics
Significant differences between mothers in studied
groups (controls, FRESH- and FET-derived pregnancies)
were observed in age (P < 0.0001, two-way ANOVA) and
parity (P = 0.003, two-way ANOVA), but not in maternal
BMI (Table 1). Finnish and Estonian mothers differed
significantly in age (P = 0.005, two-way ANOVA) and
parity (P = 0.04, two-way ANOVA); however, the inter-
action effect was not significant (P = 0.8, P = 1, respect-
ively). There was a significant difference in gestational
age between the study groups (P = 0.002, two-way
ANOVA), as well as between the Finnish and Estonian
study populations (P = 0.01, two-way ANOVA), although
the interaction effect was not significant (P = 0.7).
Furthermore, ART had no effect on the 5 min Apgar
score which is used to evaluate the vitality of the new-
born at birth.
Birth weight, birth length, and head circumference were
examined for FRESH and FET derived as well as control
newborns using international growth standards [31]. The
placental weights differed significantly between the
controls, FRESH- and FET-derived newborns (P = 0.04,
two-way ANOVA) (Table 1, Fig. 2a). Although there was a
significant difference in the placental weights between
Finnish and Estonian newborns (P < 0.001, two-way
ANOVA), the interaction effect was not significant (P =
0.4) and the data was combined. Placentas of FET-derived
pregnancies were heavier compared to FRESH-derived
placentas and control placentas (P < 0.001, P = 0.01,
respectively, Bonferroni post hoc). Also FRESH-derived
placentas were lighter compared to controls (P = 0.01,
Bonferroni post hoc) (Fig. 2a). According to the inter-
national growth standards, the standard deviations (SDs)
Fig. 1 Schematic structure of insulin-like growth factor 2 (IGF2)/H19 locus on chromosome 11p15.5. Imprinting control region with seven binding
sites for CTCF protein controls the function of the locus. H19 is expressed from maternal allele (above) and IGF2 from paternal allele (below). The
studied region of CTCF6 nucleotide sequence is presented with bolded CpG sites. Underlined sequence presents the CTCF binding site. The
rs10732516 polymorphism C/T, in which T deletes the 10th CpG site, is marked by a square
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Table 1 General characteristics of the controls, fresh embryo transfer (FRESH) and frozen embryo transfer (FET)-derived newborns,
and their mothers included in the study. The SD of measures based on international growth references adjusted for gestational age
at birth and gender. The mean values ± SD are presented and the significant difference between studied groups for total amount of
samples is calculated by Two-Way ANOVA (P value)
Country Control (n = 157) Fresh embryo transfer
(FRESH) (n = 62)
Frozen embryo transfer
(FET) (n = 24)
P value
Newborns
Birth weight (g) Total 3700 ± 436 3525 ± 548 3805 ± 601 0.02
FI 3667.7 ± 412.2 (n = 100) 3443.4 ± 502.8 (n = 29) 3846.3 ± 451.4 (n = 18)
EE 3758.9 ± 473.9 (n = 57) 3595.8 ± 582.4 (n = 33) 3679.8 ± 970 (n = 6)
Birth weight SD Total 0.21 ± 0.8 0.1 ± 1 0.6 ± 1 NS
FI 0.1 ± 0.9 (n = 100) − 0.1 ± 0.9 (n = 29) 0.6 ± 0.9 (n = 18)
EE 0.4 ± 0.6 (n = 57) 0.4 ± 1 (n = 33) 0.6 ± 0.9 (n = 6)
Length (cm) Total 51.0 ± 1.9 50.3 ± 2.3 51.1 ± 2.3 0.04
FI 51 ± 2 (n = 100) 50 ± 2 (n = 29) 51 ± 2 (n = 18)
EE 51 ± 2 (n = 57) 51 ± 2 (n = 33) 51 ± 4 (n = 6)
Length SD Total − 0.1 ± 0.8 − 0.1 ± 0.8 0.1 ± 0.8 NS
FI − 0.2 ± 0.9 (n = 100) − 0.3 ± 0.8 (n = 29) − 0.0 ± 0.9 (n = 18)
EE 0.2 ± 0.8 (n = 57) 0.1 ± 0.7 (n = 33) 0.6 ± 0.5 (n = 6)
Head circumference (cm) Total 35.5 ± 1.3 (n = 155) 35.2 ± 1.7 35.4 ± 1.9 NS
FI 35.5 ± 1 (n = 100) 34.7 ± 2 (n = 29) 35.6 ± 2 (n = 18)
EE 35.5 ± 1 (n = 55) 35.5 ± 2 (n = 33) 34.9 ± 2 (n = 6)
Head circumference SD Total 0.3 ± 0.8 (n = 155) 0.3 ± 1.1 0.4 ± 1.3 NS
FI 0.3 ± 0.9 (n = 100) −0.1 ± 1 (n = 29) 0.4 ± 1.4 (n = 18)
EE 0.4 ± 0.8 (n = 55) 0.7 ± 1 (n = 33) 0.4 ± 0.7 (n = 6)
Placenta (g) Total 565 ± 141 514 ± 118 (n = 61) 642 ± 187 0.04
FI 626.5 ± 126.4 (n = 100) 578.4 ± 105.3 (n = 29) 687.4 ± 176 (n = 18)
EE 456.7 ± 90.5 (n = 57) 454.8 ± 97.9 (n = 32) 504.5 ± 159.6 (n = 6)
Gestational age (weeks) Total 40.3 ± 1.2 39.6 ± 1.4 39.8 ± 1.7 0.002
FI 40.4 ± 1 (n = 100) 39.9 ± 1.3 (n = 29) 40 ± 1 (n = 18)
EE 40 ± 1.4 (n = 57) 39.3 ± 1.4 (n = 33) 39.3 ± 3 (n = 6)
Males Total 53% 55% 58% NS
FI 52% 41% 67%
EE 54% 67% 33%
Females Total 47% 45% 42% NS
FI 48% 59% 33%
EE 46% 33% 67%
Apgar score (5 min) Total 9 ± 1 (n = 156) 9 ± 1 9 ± 1 NS
FI 9 ± 1 (n = 100) 9 ± 0.5 (n = 29) 9 ± 0.5 (n = 18)
EE 9 ± 1 (n = 56) 9 ± 0.7 (n = 33) 9 ± 0.8 (n = 6)
Mothers
Age (years) Total 31 ± 5 34 ± 5 35 ± 4 < 0.001
FI 32 ± 5 (n = 100) 35 ± 4 (n = 29) 36 ± 3 (n = 18)
EE 29 ± 6 (n = 57) 33 ± 5 (n = 33) 33 ± 5 (n = 6)
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of birth weight (Fig. 2b) or head circumference did not
differ significantly between the Finnish and Estonian new-
borns or between the studied groups. Birth length differed
significantly between Finnish and Estonian newborns
(P = 0.001, two-way ANOVA), although the interaction
effect was not significant (P = 0.9) and no difference could
be observed between the study groups (P = 0.2). We did
not observe significant differences between sexes, when all
samples were compared.
DNA methylation profiles at H19 ICR, H19 DMR, and LINE-1
To explore the potential association between ART and
placental DNA methylation changes, we compared the
methylation levels of H19 imprinting control region (ICR)
and H19 differentially methylated region (DMR) by
EpiTYPER (Sequenom). We did not observe differences
between ART and control placentas (Additional file 2:
Table S1). We also determined the effects of ART on
global methylation level in placenta by examining methy-
lation in LINE-1 by EpiTYPER. However, we did not
observe any significant alterations in global methylation
level either (Additional file 2: Table S1).
Genotype-specific DNA methylation at H19 ICR and H19
DMR by EpiTYPER
Owing to the genotype-specific DNA methylation pro-
files of CTCF6 at H19 ICR [27], we divided our samples
into four groups according to the genotype: rs10732516
G/G, paternal G/maternal A (patG/matA), paternal A/
maternal G (patA/matG), and A/A. The allele frequen-
cies of this polymorphism are almost equal in Finnish
population (G = 0.47, A = 0.53) [32], and there were no
differences in the prevalence of rs10732516 genotypes
Table 1 General characteristics of the controls, fresh embryo transfer (FRESH) and frozen embryo transfer (FET)-derived newborns,
and their mothers included in the study. The SD of measures based on international growth references adjusted for gestational age
at birth and gender. The mean values ± SD are presented and the significant difference between studied groups for total amount of
samples is calculated by Two-Way ANOVA (P value) (Continued)
Country Control (n = 157) Fresh embryo transfer
(FRESH) (n = 62)
Frozen embryo transfer
(FET) (n = 24)
P value
Parity Total 0.7 ± 0.9 0.3 ± 0.5 0.4 ± 0.6 0.003
FI 0.6 ± 0.7 (n = 100) 0.2 ± 0.5 (n = 29) 0.3 ± 0.5 (n = 18)
EE 0.8 ± 1 (n = 57) 0.4 ± 0.6 (n = 33) 0.7 ± 0.8 (n = 6)
BMI Total 23.1 ± 4 (n = 155) 23.0 ± 4 24.2 ± 4 NS
FI 22.8 ± 3.5 (n = 99) 22.9 ± 3.4 (n = 29) 23.8 ± 3.4 (n = 18)
EE 23.7 ± 5 (n = 56) 23.2 ± 5 (n = 33) 25.5 ± 4.3 (n = 6)
FI Finland, EE Estonia, NS not significant
a b
Fig. 2 Placental weights and birth weights (SD) of control, fresh embryo transfer (FRESH) and frozen embryo transfer (FET) derived newborns.
a The placental weights differ significantly between the groups (P = 0.04, Two-Way ANOVA). FET-derived placentas are heavier compared to
FRESH (P = 0.001, Bonferroni pos hoc) and FRES-derived lighter compared to controls (P = 0.01, Bonferroni post hoc). b There are no significant
differences in birth weights between the groups. Bonferroni post hoc test for Two-Way ANOVA. Bonferroni post hoc test for two-way ANOVA:
*P < 0.05, **P < 0.01, ***P ≤ 0.001
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between controls and ART-derived samples in this study
(X2(3) = 5.52, P = 0.138, chi-square test).
We compared first the genotype-specific methylation
levels of placental CTCF6 at H19 ICR and H19 DMR by
EpiTYPER to explore potential effects of ART. We did
not see any genotype-specific differences between con-
trol and ART samples at H19 ICR (Additional file 2:
Table S1). At the H19 DMR, we observed increased
methylation level in CpG_3 and CpG_16 units in A/A
genotype of ART samples (nominal P values: P = 0.03
and P = 0.05, respectively, Student’s t test), but changes
were not significant after Bonferroni multiple testing
correction.
Genotype-specific DNA methylation at H19 ICR by
bisulfite sequencing
We also compared genotype-specific methylation levels of
CTCF6 at H19 ICR between control and ART placentas
by traditional bisulfite sequencing. To discern maternal
and paternal alleles, we used only heterozygous samples
(patG/matA and patA/matG). We observed a bias in PCR
product: hypomethylated maternal allele of patA/matG
genotype was amplified more efficiently compared to
hypermethylated paternal allele. Owing to that, we
counted the average methylation percentages separately
for both alleles and then calculated the total methylation
level for each CpG sites (CpG_1-27). We observed similar,
but much more prominent common genotype-specific
methylation profiles in placenta as we detected by EpiTY-
PER (Additional file 2: Table S1 and S2).
When comparing genotype-specific DNA methylation
within heterozygotes (patG/matA and patA/matG) con-
trols to ART samples, we observed decreased methylation
level at sites CpG_1-3, CpG_5, CpG_14, and CpG_24
patA/matG genotype in the ART placentas (nominal P
values 0.008, 0.02, 0.001, 0.013, 0.013, and 0.029, respect-
ively, Mann-Whitney) (Fig. 3d). Instead of hypomethyla-
tion, we observed increased methylation level at site
CpG_26 in patG/matA genotype (nominal P value = 0.041,
Mann-Whitney). However, changes in methylation level
were not significant after multiple testing correction.
We did not see similar trend of decreased methylation
Fig. 3 Genotype- and allele-specific DNA methylation levels at H19 ICR (CTCF6) in control and ART placentas measured by traditional bisulfite
sequencing. Methylation levels of selected CpG sites in the a patG/matA genotype, b paternal allele of patG/matA genotype, c maternal allele of
patG/matA genotype, d patA/matG genotype, e paternal allele of patA/matG genotype, and f maternal allele of patA/matG genotype. Error bars
denote the SD. The numbers of samples are in brackets. A star (★) illustrates nominal P value < 0.05, Mann–Whitney
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in the patA/matG genotype by EpiTYPER method
(Additional file 2: Table S1 and S2), which could be
explained by the amplification bias in PCR.
Allele-specific DNA methylation at H19 ICR
We next assessed the allele-specific methylation levels of
CTCF6 at H19 ICR in heterozygous genotypes (patG/
matA and patA/matG) in placenta by bisulfite sequencing.
When comparing the methylation levels of paternal and
maternal alleles separately in control and ART samples,
we observed consistently decreased methylation level in
paternal allele of patA/matG genotype at sites CpG_1-5,
CpG_14, CpG_24, and CpG_25 in ART placentas (nominal
P values 0.013, 0.013, 0.001, 0.029, 0.013, 0.003, 0.005, and
0.029, respectively,Mann-Whitney) (Fig. 3e, Additional file 2:
Table S2). Conversely, increased methylation level was
observed at site CpG_26 in the maternal allele of patA/
matG genotype (nominal P value = 0.005, Mann Whitney)
(Fig. 3f), and both increased and decreased methylation at
sites CpG_24 and CpG_26, respectively, in the paternal
allele of patG/matA genotype (nominal P value = 0.026 and
0.015, respectively, Mann-Whitney) (Fig. 3b). However,
changes in methylation levels were not significant after
multiple testing correction.
To see if similar decreased methylation level in patA/
matG genotype can be seen also in the blood, we exam-
ined white blood cells (WBCs) of newborns’ umbilical
cord blood from the same ART-derived pregnancies.
However, we did not observe similar decreased methyla-
tion level in the paternal allele of patA/matG genotype in
ART-derived WBCs as we saw in placental tissue (Fig. 4,
Additional file 2: Table S3). Conversely, a subtle but con-
sistent increased methylation level in ART-derived WBCs
was detected. The methylation level of CpG_4 site in the
paternal allele of ART samples was clearly increased (P =
0.03, Mann-Whitney), but the difference is not significant
after multiple testing correction.
Genotype-specific phenotypes of newborns
Finally, we assessed genotype-specific phenotypes of
newborns by using international growth standards.
Genotype-specific examination revealed differences in
FRESH-derived newborns’ birth weight and head circum-
ference (P = 0.04 and P = 0.004, respectively, one-way
ANOVA). FRESH-derived newborns with G/G genotype
were heavier (P = 0.04, Bonferroni post hoc) and had
larger head circumference (P = 0.002, Bonferroni post hoc)
compared to newborns with A/A genotype (Fig. 5a, b).
We did not observe significant differences in birth length.
Genotype-specific differences were not compared in the
FET-derived newborns since the sample size was too low
in the heterozygous genotypes. We also saw that the
placental weight and birth weight differed significantly
between controls, FRESH-derived and FET-derived new-
borns in the A/A genotype (P = 0.024 and P = 0.006,
one-way ANOVA) (Fig. 5a, c). Both the placentas and
newborns of FET-derived pregnancies were heavier than
FRESH-derived pregnancies (P = 0.02 and P = 0.004, re-
spectively, Bonferroni post hoc). We did not see similar
differences between the groups in the G/G genotype.
Discussion
Owing to the decreased birth weight and decreased methy-
lation level at the H19 ICR associated previously with IVF
treatments, we focused on the imprinted IGF2/H19 locus,
which is crucial for normal placental and embryonic
growth. In our previous study, a polymorphism rs10732516
at this locus associated with a genotype-specific trend in
placental DNA methylation and head circumference of
prenatally alcohol-exposed newborns [27]. Due to the
growth-restricted phenotype in both prenatal alcohol
exposure and IVF, we explored if these rather different
environmental factors could associate with similar changes.
We observed consistently decreased DNA methylation at
the sixth binding site (CTCF6) of H19 ICR in ART-derived
placentas, which is consistent with previous ART study
Fig. 4 Genotype- and allele-specific DNA methylation levels at H19 ICR (CTCF6) of patA/matG genotype in control and ART-derived white blood
cells (WBCs) by traditional bisulfite sequencing. Error bars denote the SD. The numbers of samples are in brackets. A star (★) illustrates nominal
P-value < 0.05, Mann–Whitney
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[15]. Interestingly, the decreased methylation level was de-
tected only in the paternal allele in rs10732516 patA/matG
genotype of two studied heterozygous genotypes, and alter-
ation was even more profound than in the alcohol-exposed
placentas in our previous study. This suggests that the
effect of ART on DNA methylation in placenta is
genotype-specific.
We did not observe similar changes in the methylation
level of paternal allele in WBCs from cord blood of
ART-derived newborns. This could be explained by the
more advanced differentiation stage of the extraembryonic
trophoblast cells compared to inner cell mass, the location
of the cells in the blastocyst, or the better DNA methyla-
tion repairing and maintaining mechanisms of the embry-
onic cells. However, our result is consistent with the
earlier study, where decreased methylation in this same
region was detected only in mononuclear cells, not in
WBCs [17]. This suggests that these genotype-specific
changes in methylation have not occurred in blood cells in
the early embryonic development or they are not fixed in
all cell types.
We are aware of some limitations in this study. Trad-
itional bisulfite sequencing is useful only for allele-specific
examination of heterozygous genotypes, and thus, the
methylation information about homozygous genotypes
is lacking. Furthermore, we did not observe similar trend
of decreased methylation by EpiTYPER, indicating that
as a PCR-based method, it is not a convenient method to
detect relatively small but consistent allele specific
methylation changes in this specific imprinted region.
Also, based on these results, it is not possible to see if
decreased methylation at the H19 ICR is caused by ART
or infertility.
The number of FET samples was too low to explore
the phenotypic effects on each genotype, but the
genotype-specific variation in the birth weight and head
circumference of FRESH-derived newborns suggest that
the polymorphism could associate with the growth.
Genotype-specific examination also revealed that in the
rs10732516 A/A genotype, the placental weight and
birth weight (SD) of controls, FRESH- and FET-derived
newborns, differed from each other. Interestingly, we did
not see the same in the G/G genotype. Both the placen-
tas and newborns of FET-derived pregnancies were the
heaviest in the A/A genotype. This is consistent with the in-
creased head circumference of prenatally alcohol-exposed
children [27] as well as the strongest growth phenotype of
infantile hemangiomas [33], which both associate with this
specific genotype.
Conclusion
Both genotype-specific methylation profiles and phenotypic
findings suggest that rs10732516 polymorphism associates
with the effects of ART in a parent-of-origin manner. The
polymorphism locates on the binding sequence of CTCF
protein, and allele A deletes a CpG binding site for a methyl
group. Whether the A allele affects slightly the binding effi-
ciency of CTCF protein and consequently makes A/A
genotype particularly sensitive to environmental factors, it
needs to be clarified in functional studies. More studies are
also needed to find out if changes in this locus have oc-
curred already in the very beginning of the embryonic de-
velopment, in the period of epigenetic reprogramming, and
the causality of the alterations: could the genotype-specific
changes in DNA methylation affect the gene expression
and thus the phenotype of developing embryo. Owing to
Fig. 5 Genotype-specific placental weight, birth weight (SD), and head circumference (SD) of controls, fresh embryo transfer (FRESH), and frozen
embryo transfer (FET)-derived newborns. a Genotype-specific differences in birth weight of FRESH-derived newborns were observed (P = 0.04, one-way
ANOVA): newborns with G/G in genotype were heavier compared to newborns with A/A (P = 0.04, Bonferroni post hoc). Birth weights (SD) of studied
groups differ significantly in A/A genotype (P = 0.006, one-way ANOVA). FET-derived newborns are heavier compared to FRESH newborns (P = 0.004,
Bonferroni post hoc). b Genotype-specific differences in head circumference of FRESH-derived newborns were observed (P = 0.004, one-way ANOVA):
newborns with G/G genotype had larger head circumference compared to newborns with A/A (P = 0.002, Bonferroni post hoc). c Placental weights (g)
differ significantly between the studied groups in A/A genotype (P = 0.024, One-way ANOVA). FET-derived placentas are heavier compared to FRESH
(P = 0.02, Bonferroni post hoc). Error bars denote the SD. The numbers of samples are shown above the genotypes. Bonferroni post hoc test for
one-way ANOVA: *P < 0.05, **P < 0.01, ***P≤ 0.001
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the genotype-specific methylation changes at the H19 ICR
in ART-derived placentas and previous associations be-
tween ART and imprinting disorders, it would be interest-
ing to find out if the prevalence of imprinting disorders
associates with the rs10732516 G/A polymorphism.
Methods
Study design and sample collection
Couples applied to fertilization treatment in the Repro-
ductive Medicine Unit of Helsinki University Central
Hospital, Finland or Fertility Clinic of the Family Feder-
ation of Finland or Tartu University Hospital were re-
cruited to this study. IVF or ICSI have been used in the
treatments. The conception has been done using fresh
embryo transfer (FRESH) or frozen embryo transfer
(FET). Placental and cord blood samples from 47
Finnish cases (29 FRESH: 23 IVF/6 ICSI and 18 FET: 12
IVF/6 ICSI) are collected during years 2013–2017 and
39 Estonian cases (33 FRESH: 21 IVF/12 ICSI and 6
FET: 3 IVF/3 ICSI) 2016–2017. Spontaneously conceived
100 Finnish controls have been collected during years
2013–2015 in Helsinki University Central Hospital,
Finland [27], and 57 Estonian controls in Tartu Univer-
sity Hospital. All the samples were Caucasian origin,
from Finnish and Estonian newborns. Sample informa-
tion and variation between Finnish and Estonian samples
are shown in Table 1 and Additional file 1: Table S1.
The placental biopsies (1 cm3) and umbilical cord blood
samples were collected immediately after delivery. The
placental biopsies were collected from the fetal side of pla-
centa within a radius of 2–3 cm from the umbilical cord,
rinsed in cold 1× PBS and stored in RNAlater® (Thermo
Fisher Scientific, Vilnius, Lithuania) at − 80 °C. White
blood cells (WBCs) were extracted as soon as possible, at
latest 16 h after birth (Additional file 3: Protocol S1).
Birth weight (g), birth length (cm), and head circum-
ference (cm) were examined for both Finnish and Esto-
nian newborns using international growth standards, the
Fentom Preterm Growth Chart by PediTools (http://
peditools.org/), in which the gestational age at birth and
sex are considered when calculating the SD (z-score) of
birth measures [31]. This chart has also been used previ-
ously for full-term deliveries [34, 35]. Measures deviating
more than ± 2 SDs are commonly considered abnormal.
Methylation analysis
EpiTYPER
Placental genomic DNA was extracted by commercial
QIAamp Fast DNA Tissue Kit (Finnish samples, Qiagen,
Valencia, CA, USA) or PureLink Genomic DNA Kit
(Estonian samples, Invitrogen, Life Technologies, USA).
The extractions were done from one to four pieces (on
average from three pieces) of placental tissue. The total
DNA methylation levels of H19 ICR (CTCF6), H19
DMR, and LINE-1 regions in placental samples were mea-
sured by MassARRAY EpiTYPER (SEQUENOM Inc.)
based on matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometry. First,
DNA (1000 ng) was bisulfite converted (EZ-96 DNA
Methylation™ kit, Zymo Research, Irvine, CA, USA) and
PCR was performed in three independent 10 μl reactions
using HotStar PCR kit (Qiagen, Valencia, CA, USA)
according to manufacturer’s instructions. Primers for the
regions of interest were obtained from previous publica-
tions [36, 37] (Additional file 3: Table S2). The EpiTYPER
measurements were done for pooled PCR reactions.
Altogether, 60 controls and 62 ART-derived (48 FRESH:
33 IVF/15 ICSI and 14 FET: 8 IVF/6 ICSI) Finnish and
Estonian placental samples were analyzed by EpiTYPER.
Bisulfite sequencing
To find out the allele-specific methylation profiles and to
confirm the EpiTYPER results as well as genotypes, the
CTCF6 at H19 ICR of heterozygous ART-derived placen-
tal samples with patG/matA genotype (4 FRESH: 4 IVF,
and 2 FET: 1 IVF/1 ICSI) and patA/matG genotype (7
FRESH: 4 IVF/3 ICSI, and 1 FET: IVF), and eight WBC
samples with patA/matG genotype (4 controls and 4
ART-derived samples: 3 FRESH: 1 IVF/2 ICSI, and 1 FET:
IVF) were subjected to bisulfite sequencing. All the sam-
ples were from Finnish newborns. The control placental
samples had been published previously [27]. Due to
heterozygosity and imprinting, the paternal and maternal
alleles could be distinguished. Two separate bisulfite
conversions were performed for 500 ng of genomic DNA
(EZ DNA Methylation™ kit, Zymo Research, Irvine, CA,
USA) and pooled afterwards. To avoid possible PCR bias,
three independent 20 μl PCR reactions (HotStar PCR kit,
Qiagen, Valencia, CA, USA) were performed per sample.
Primers were obtained from previous publication and
allowed to detect the polymorphism in units
CpG_17,18,19,20 [38] (Additional file 2: Table S3). PCR
reactions were gel isolated, and the three reactions of each
sample were pooled and purified using NucleoSpin Gel
and PCR Clean-up Kit (Macherey-Nagel, Düren,
Germany). The purified PCR fragments were ligated into
pGEM®-T Easy Vector (Promega, Madison, WI, USA) and
cloned by standard protocol. The recombinant-DNA
clones were purified using NucleoSpin® Plasmid EasyPure
kit (Macherey-Nagel, Düren, Germany) according to
manufacturer’s instructions. Fifty to eighty clones of each
individual were sequenced. The sequences were analyzed
by BIQ Analyzer [39] excluding the clones with lower
than 90% conversion rate from the dataset.
Genotype analysis
Placental samples were genotyped by Sanger sequencing.
According to our sequencing analyses, the heterozygous
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samples were able to distinguish from each other due to
uneven amplification and hence different signal levels of
the alleles. The peak of rs10732516 A in sequence of
patA/matG genotype was lower compared to patG/matA
genotype. One 20 μl PCR reaction was performed for
each sample using commercial HotStar PCR kit (Qiagen
Valencia, CA, USA) with 100–300 ng of template DNA.
Primers were designed by using NCBI/Primer Blast
(Additional file 3: Table S2). PCR products were purified
with SAP treatment (FastAP Thermosensitive Alkaline
Phosphatase (1 U/μL), Thermo Scientific, Waltham, MA,
USA) according to manufacturer’s instructions. The
genotypes of samples that were analyzed by EpiTYPER
could be confirmed by detecting genotype-specific frag-
mentation and distinct methylation levels in unit CpG_10
of H19 ICR. The methylation level in patG/matA was
~ 0.80, in G/G ~ 0.30, in patA/matG ~ 0.02, and in
A/A there was no value.
Statistical analysis
Statistical analyses were conducted using either SPSS
software for Windows version 22.0 (NY, USA) or Graph-
Pad Prism 7 software (GraphPad Software, Inc., La Jolla,
CA, USA). All data are expressed as the mean with ±SD
for a normal distribution of variables. Samples were
divided into four groups according to the genotype and
the chi-square test was used to compare the prevalence
of the rs1072516 in the control and ART samples. The
non-parametric Mann–Whitney test was used to com-
pare the methylation level of CpG sites analyzed by bi-
sulfite sequencing. Student’s t test was used to compare
CpG units analyzed by EpiTYPER. In the methylation
analysis, the nominal P value was considered significant
when < 0.05 and Bonferroni correction was used for
multiple testing correction. Two-way ANOVA, followed
by Bonferroni post hoc test when significant, was used
to identify the differences among the study groups as
well as to eliminate the interaction effect if significant
differences between the Finnish and Estonian newborns
were observed.
Additional files
Additional file 1: Table S1. Information of ART samples. (PDF 165 kb)
Additional file 2: Table S1. DNA methylation levels of H19 ICR (CTCF6),
H19 DMR and LINE-1 in control and ART-derived placentas by EpiTYPER
method. Methylation average values with SDs (±) of CpG units are
presented. Gray boxes present significant methylation level difference
at CpG sites in H19 DMR between ART and control samples within A/A
genotype (nominal p-value < 0.05, Student’s t-test). Table S2. Total,
rs10732516 genotype-specific (patG/matA and patA/matG) and
allele-specific (paternal and maternal) DNA methylation levels at H19 ICR
(CTCF6) in control and ART-derived placentas by traditional bisulfite
sequencing. Gray boxes present significant methylation level difference
at CpG sites between control and ART samples within genotypes and
alleles (nominal p-value < 0.05, Mann-Whitney). Total methylation levels:
total means of both genotypes and both alleles are included. Genotype-
specific methylation levels: total means of both alleles are included.
Allele-specific methylation levels: maternal and paternal alleles are
presented separately. Table S3. rs10732516 patA/matG genotype- and
allele-specific DNA methylation levels at H19 ICR1 (CTCF6) in controls
and ART-derived newborns’ white blood cells (WBCs) in cord blood by
traditional bisulfite sequencing. Genotype-specific methylation levels:
total means of both alleles are included. Allele-specific methylation levels:
maternal and paternal alleles are presented separately. (PDF 145 kb)
Additional file 3: Protocol S1. Extraction of total white blood cells
(WBC) from EDTA-tube. Table S2. Primers (A) and PCR reactions (B).
(PDF 306 kb)
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